Siegel, Corey | Digital Healthcare Research

Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: A cluster randomised controlled trial.

Citation

Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DT, Regueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: A cluster randomised controlled trial. Aliment Pharmacol Ther. 2023 Jan;57(2):205-214. doi: 10.1111/apt.17286. Epub 2022 Nov 14. PMID: 36377259; PMCID: PMC9790033.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease - Final Report

Citation

Siegel C. Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease - Final Report. (Prepared by Dartmouth College under Grant No. R01 HS021747). Rockville, MD: Agency for Healthcare Research and Quality, 2019.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.

Citation

Siegel CA, Horton H, Siegel LS, et al. A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables. Aliment Pharmacol Ther 2016 Jan;43(2):262-71. PMID: 26567467.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Novel statistical approach to determine inflammatory bowel disease: patients' perspectives on shared decision making.

Citation

Siegel CA, Lofland JH, Naim A, et al. Novel statistical approach to determine inflammatory bowel disease: patients' perspectives on shared decision making. Patient 2016 Feb;9(1):79-89. PMID: 25963447.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications.

Citation

Thompson KD, Connor SJ, Walls DM, et al. Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications. Inflamm Bowel Dis 2016 Apr;22(4):940-7. PMID: 26950308.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn’s disease: a network meta-analysis.

Citation

Hazlewood GS, Rezaie A, Borman M, et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn’s disease: a network meta-analysis. Gastroenterology 2015;148(2):344–54. PMID: 25448924.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Patients with Crohn’s disease are more likely to remain on biologics than immunomodulators: a meta-analysis of treatment durability.

Citation

Shah ED, Siegel CA, Chong K, et al. Patients with Crohn’s disease are more likely to remain on biologics than immunomodulators: a meta-analysis of treatment durability. Dig Dis Sci 2015;60(8):2408–18. PMID: 25772778.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Beware of the swinging pendulum: anti-tumor necrosis factor monotherapy vs combination therapy for inflammatory bowel disease.

Citation

Bressler B, Siegel CA. Beware of the swinging pendulum: anti-tumor necrosis factor monotherapy vs combination therapy for inflammatory bowel disease. Gastroenterology 2014 Apr;146(4):884-7.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Citation

Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013 Dec;19(13):2927-36.

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn’s Disease - 2012

Principal Investigator

Siegel, Corey

Project Name

Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease